Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-02

Clinical Trial Update: Study of Milnacipran for the Treatment of Fibromyalgia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating milnacipran for fibromyalgia has completed and results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SAVELLA (milnacipran hydrochloride)

Snippet

Sponsor: Forest Laboratories | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED | Results posted: 2009-11-02